We’re thrilled to announce that Eden AI has successfully raised €3M in funding to Revolutionize the AI Landscape! Eden AI helps companies find and benchmark (performance, cost, availability) the best AI models for their needs and connects them through one single API. Congratulations Taha, Samy and the whole team on this new milestone! We are very proud to accompany and support you ?? We're excited to join forces with 50 Partners, an amazing group of investors, including Alix de Sagazan, Rémi Aubert, Gilles Samoun, Super Capital, Wendel-Participations SE and the existing investors, on this exciting journey. Learn more about the project : https://lnkd.in/eddnn7B6
关于我们
- 网站
-
https://galion.exe.vc
Galion.exe的外部链接
- 所属行业
- 投资管理
- 规模
- 2-10 人
- 类型
- 私人持股
Galion.exe员工
动态
-
Galion.exe转发了
Generare announces its 5m€ seed to speeds up hunt for new drugs by cloning natural molecules ?? Generare has developed a highly scalable platform that identifies promising compounds already existing in nature, focusing on molecules produced by microorganisms that can be repurposed as new treatments, including antibiotics, anticancer drugs, and agricultural alternatives. ???? Big congrats to this world-class team for their groundbreaking work in genetic engineering, decoding over 1,000 ‘genetic recipes’ within just a year, including 100+ novel molecules with antibiotic potential. ??? Cc : Guillaume Vandenesch, Vincent Libis (the tech is based on his decade of research), Baudoin Delépine, Oriane Monet, Nadège Guinot, Bismarck Olympio, Humbeline Paupelin (Vaucelle), Guido Rodrigo, Hugo Boutonnet, Anne-Camille Renaudeau, Charlotte Thiola. We are more than happy to invest alongside Teampact.ventures, VIVES Partners and an incredible group of investors. Thanks to Natasha Lomas for the article on TechCrunch (link in comments) !
-
Generare announces its 5m€ seed to speeds up hunt for new drugs by cloning natural molecules ?? Generare has developed a highly scalable platform that identifies promising compounds already existing in nature, focusing on molecules produced by microorganisms that can be repurposed as new treatments, including antibiotics, anticancer drugs, and agricultural alternatives. ???? Big congrats to this world-class team for their groundbreaking work in genetic engineering, decoding over 1,000 ‘genetic recipes’ within just a year, including 100+ novel molecules with antibiotic potential. ??? Cc : Guillaume Vandenesch, Vincent Libis (the tech is based on his decade of research), Baudoin Delépine, Oriane Monet, Nadège Guinot, Bismarck Olympio, Humbeline Paupelin (Vaucelle), Guido Rodrigo, Hugo Boutonnet, Anne-Camille Renaudeau, Charlotte Thiola. We are more than happy to invest alongside Teampact.ventures, VIVES Partners and an incredible group of investors. Thanks to Natasha Lomas for the article on TechCrunch (link in comments) !
-
Another exciting news is to announce that Galion.exe has invested in Vaire Computing as part of their $4.5M seed round with 7percent Ventures, B Heroes, Clim8 Ventures, IAG, Jude Gomila, Page One Ventures, Seedcamp, Tagus Capital, übermorgen Ventures, and Vannevar Ventures. Vaire Computing, co-founded by ??? Rodolfo Rosini and Hannah E. from the University of Cambridge, is at the cutting edge of reversible computing. This London- and Seattle-based company is innovating to produce silicon chips that significantly reduce energy consumption, addressing the critical need for more efficient AI hardware. We look forward to seeing the impact Vaire will make and are excited to support their journey toward more sustainable technology solutions. Find out more on TechCrunch: https://lnkd.in/dmHmAEZN
-
We are pleased to announce that Galion.exe has participated in Apiday's successful 10 m€ Series A founding round, gathering great co-investors such as AENU, daphni, SWEN Capital Partners, as well as existing investors Revent and Speedinvest. Founded in 2021 by Edouard Audi and Charles Moury, and headquartered in Paris, Apiday is leading the way in ESG reporting for private equity funds and SMI companies across Europe. The company’s platform combines innovative data models and advanced ESG expertise to help partners compile tailored sustainability reports in line with the latest CSRD and SFDR regulations. This funding will enable Apiday to expand its technology stack with artificial intelligence enhancements and grow its team of ESG experts, reinforcing its position as a leader in sustainable business practices. Read more on TechCrunch: https://lnkd.in/eKS9v_sF
-
?OFFRE DE STAGE? - Galion.exe - Fonds early-stage focus Tech Rejoignez l'aventure d'un fonds en création et une équipe passionnée par la Tech et l’entrepreneuriat ! En nous rejoignant, c’est l'opportunité d’être responsabilisé et de travailler en relation directe avec les partners. L'équipe est à taille humaine (2 partners et 1 CFO) et le fonds en phase d’investissement (9 deals closés à date et plusieurs en cours). ?? En tant que stagiaire, vous participerez activement à chaque phase du processus d'investissement, jouant un r?le essentiel dans la réalisation de nos objectifs stratégiques. Type de contrat : stage (6 mois) Date de début : fin ao?t / septembre 2024 Lieu : Paris ?? Vous trouverez le lien pour postuler en commentaire. #venturecapital?#stage?#entrepreneurs
-
Galion.exe转发了
Vous adorez l'innovation et la tech ? Vous aimez creuser des sujets, vous connectez avec des talents, réfléchir à des évolutions d'usages et tester de nouveaux produits ? Vous avez le coeur partagé entre la finance et l'entrepreneuriat ? Nous recrutons un principal (4-7 ans xp). Venez nous rejoindre pour investir et construire notre société de gestion. https://lnkd.in/e5NqeCgz